Evidence map›Paper›PMID 29742432›Full record

ArticleCell reports2018

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Giorgia Renga, Silvia Moretti, Vasilis Oikonomou, Monica Borghi, Teresa Zelante, Giuseppe Paolicelli, Claudio Costantini, Marco De Zuani, Valeria Rachela Villella, Valeria Raia and 9 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Bevacizumab induces ferroptosis and enhances CD8Acta pharmacologica Sinica · 2024
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 2 countries.

Giorgia RengaDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Silvia MorettiDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Vasilis OikonomouDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Monica BorghiDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Teresa ZelanteDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Giuseppe PaolicelliDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Claudio CostantiniDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Marco De ZuaniDepartment of Medical and Biological Science, University of Udine, 33100 Udine, Italy.
Valeria Rachela VillellaEuropean Institute for Research in Cystic Fibrosis, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy.
Valeria RaiaRegional Cystic Fibrosis Center, Pediatric Unit, Department of Translational Medical Sciences, Federico II University Naples, 80131 Naples, Italy.
Rachele Del SordoDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Andrea BartoliDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Monia BaldoniDepartment of Medicine, University of Perugia, 06132 Perugia, Italy.
Jean-Christophe RenauldLudwig Institute for Cancer Research, Brussels Branch, 1200 Brussels, Belgium.
Angelo SidoniDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Enrico GaraciSan Raffaele Pisana, IRCCS, Telematic University and University of Tor Vergata, 00163 Rome, Italy.
Luigi MaiuriEuropean Institute for Research in Cystic Fibrosis, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy; Department of Health Sciences, University of Piemonte Orientale, 28100 Novara, Italy.
Carlo PucilloDepartment of Medical and Biological Science, University of Udine, 33100 Udine, Italy.
Luigina RomaniDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy. Electronic address: luigina.romani@unipg.it.
University of Perugia · ITUniversity of Udine · ITFederico II University Hospital · ITLudwig Cancer Research · BEUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Candida albicans is implicated in intestinal diseases. Identifying host signatures that discriminate between the pathogenic versus commensal nature of this human commensal is clinically relevant. In the present study, we identify IL-9 and mast cells (MCs) as key players of Candida commensalism and pathogenicity. By inducing TGF-β in stromal MCs, IL-9 pivotally contributes to mucosal immune tolerance via the indoleamine 2,3-dioxygenase enzyme. However, Candida-driven IL-9 and mucosal MCs also contribute to barrier function loss, dissemination, and inflammation in experimental leaky gut models and are upregulated in patients with celiac disease. Inflammatory dysbiosis occurs with IL-9 and MC deficiency, indicating that the activity of IL-9 and MCs may go beyond host immunity to include regulation of the microbiota. Thus, the output of the IL-9/MC axis is highly contextual during Candida colonization and reveals how host immunity and the microbiota finely tune Candida behavior in the gut.

Indexed as

Adaptive ImmunityAnimalsCandida albicansCandidiasisCeliac DiseaseCell Membrane PermeabilityDisease Models, AnimalEpithelial CellsHumansImmunity, InnateIndoleamine-Pyrrole 2,3,-DioxygenaseInterleukin-9Intestinal MucosaIntestinesMast CellsMice, Inbred C57BLIDO1 protein, mouseIndoleamine-Pyrrole 2,3,-DioxygenaseInterleukin-9Receptors, Interleukin-9Candida albicansceliac diseaseIDO1IL-9intestinal inflammationmast cells

Identifiers

PMID29742432
PMCPMC5976578
OpenAlexW2799409928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.